5 %The prevalence of HIV sero-discordance among in-union HIV patients receiving care in a private health facility in Jos, north central Nigeria, was 5.0%.
NigeriaVIH/sidapublished 2022West African journal of medicinePubMeddocument of 16 observations
Gold tier: mechanically validated evidence, with its primary source.
1,729 evidence items · page 57 / 70
5 %The prevalence of HIV sero-discordance among in-union HIV patients receiving care in a private health facility in Jos, north central Nigeria, was 5.0%.
NigeriaVIH/sidapublished 2022West African journal of medicinePubMeddocument of 16 observations
2.74 odds_ratioHIV seroprevalence increased with an odds ratio of 2.74 (95% CI, 1.10–7.11; P = .02) compared with historical trends.
NigeriaVIH/sidapublished 2022JAMA network openPubMeddocument of 7 observations
2.35 aHRHIV co-infection significantly increased probability of mortality among DR-TB patients, with an adjusted hazard ratio (aHR) of 2.35.
NigeriaDrug-Resistant tuberculosis (DR-TB) · VIH/sidapublished 2019PloS onePubMeddocument of 10 observations
95 %Among 2,958 persons identified as HIV-positive using the national testing algorithm in the Nigeria AIDS Indicator and Impact Survey (NAIIS) 2018, 2,800 (95%) were confirmed HIV-positive by supplemental Geenius HIV-1/2 testing.
NigeriaVIH/sidaobserved 2018published 2022PLOS global public healtheurope_pmcdocument of 10 observations
3.5 %The prevalence of hepatitis B surface antigenemia among HIV positive patients on anti-retroviral treatment programme in Anyigba, Kogi State, North-Central Nigeria was 3.5%.
Nigeriahépatite B · VIH/sidapublished 2019African health sciencesPubMed
85 %85% of the 903 entries (n = 769) were eligible and scored for feasibility, impact, and desirability.
NigeriaVIH/sidaobserved October 2018 to June 2019published 2020PloS onePubMeddocument of 10 observations
45.4 %Among 262 health care workers in a tertiary health facility in Kano, Nigeria, 45.4% (n=119) listed human milk substitutes as an appropriate feeding choice for HIV-exposed infants.
NigeriaVIH/sidapublished 2020Current HIV researchPubMeddocument of 7 observations
49.97 kgThe mean weight of age-matched HIV-negative controls was 49.97 ± 13.58 kg.
NigeriaVIH/sidapublished 2022BMC pediatricsPubMeddocument of 6 observations
77.1 %Viral suppression at <1000 copies/mL at 12 months was 77.1% (158/205) for point-of-care monitoring and 65.9% (137/208) for standard-of-care monitoring in per-protocol analysis.
NigeriaVIH/sidaobserved 12 monthspublished 2023Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 5 observations
50 %About 50% of individuals needing HIV treatment in Nigeria are unable to access required services.
NigeriaVIH/sidapublished 2022Global health, science and practicePubMeddocument of 4 observations
30 %HIV testing uptake among undergraduate students in Imo State, Nigeria, was 30% at Federal Polytechnic Nekede (FEP) in the past year.
NigeriaVIH/sidapublished 2026Scientific reportsPubMeddocument of 5 observations
Use of antiretroviral therapy among HIV-infected children is associated with a higher health-related quality of life (QoL) in the general health rating, physical resilience, functional score, symptom, social and role functioning domains.
NigeriaVIH/sidapublished 2020West African journal of medicinePubMeddocument of 8 observations
5 casesFive (5.5%) participants were positive for HIV 1 & 2.
NigeriaVIH/sidapublished 2020Journal of immunoassay & immunochemistryPubMeddocument of 8 observations
95.6 %Among 91 HIV-1 infected individuals in Abakaliki metropolis, Ebonyi State, Nigeria, 87 (95.6%) were positive for Epstein-Barr Nuclear Antigen (EBNA) IgG antibody.
NigeriaVIH/sida · virus Epstein-Barrpublished 2020Journal of immunoassay & immunochemistryPubMeddocument of 15 observations
Nigeria ranked third in the world by number of people living with HIV/AIDS in 2019.
NigeriaVIH/sidaobserved 2019published 2020African journal of AIDS research : AJARPubMeddocument of 3 observations
14.7 %Adolescents and young adults (AYA) who engaged in transactional sex had higher facility-based HIV testing uptake by an unadjusted risk difference of 14.7%, compared to AYA who never engaged in transactional sex.
NigeriaVIH/sidapublished 2026AIDS (London, England)PubMeddocument of 7 observations
36.2 %The middle-aged population (40–59 years) constituted 36.2% of HIV/AIDS admissions.
NigeriaVIH/sidapublished 2023West African journal of medicinePubMeddocument of 11 observations
36.3 %In a study of 146 HIV-infected children in Calabar, Nigeria, conducted from February 1 to September 30, 2015, the prevalence of renal disease was 36.3%.
Nigeriarenal disease · VIH/sidaobserved February 1 to September 30, 2015published 2022Saudi journal of kidney diseases and transplantation : an official publication of the SaudPubMeddocument of 5 observations
46.8 %46.8% of community pharmacists cited lack of clinical tools as a barrier to integrating HIV/AIDS services into practice.
NigeriaVIH/sidaobserved 2019published 2021International journal of STD & AIDSPubMeddocument of 11 observations
4.8 %HIV prevalence was 4.8% in adults aged 15 years and older in the Akwa Ibom AIDS Indicator Survey.
NigeriaVIH/sidapublished 2020PloS onePubMeddocument of 4 observations
20 copies/mLAmong PLHIV at FMC Katsina, the median viral load was 20 (interquartile range: 20–40) copies/mL in virally suppressed patients.
NigeriaVIH/sidaobserved 2009–2019published 2021BMC infectious diseasesPubMeddocument of 5 observations
73 %At baseline, 73% of respondents at Akwakuma Girls Secondary School had poor knowledge of HIV/AIDS mode of transmission and prevention.
NigeriaVIH/sidapublished 2024BMC public healthPubMeddocument of 5 observations
22.98 scoreThe mean total score of community pharmacists' involvement in antiretroviral (ARV) medication therapy management (MTM) was 22.98 ± 19.61, with a range of 9–45 and midpoint 27.
NigeriaVIH/sidaobserved 2019published 2021International journal of STD & AIDSPubMeddocument of 11 observations
0.018 AORMothers initiating ART before pregnancy had lower odds of an HIV-positive child after 18 months compared to those who initiated ART after birth (adjusted odds ratio 0.018).
NigeriaVIH/sidapublished 2026BMC infectious diseasesPubMeddocument of 10 observations
28 %Among people living with HIV in Osun State, Nigeria, the prevalence of hyperglycaemia was 28%.
Nigeriahyperglycaemia · VIH/sidapublished 2026BMC infectious diseasesPubMeddocument of 9 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.